Illumina, Inc. (NASDAQ:ILMN) will speak at the Piper Jaffray health Care Conference on Wednesday, December 2. The conference is set to take place at the New York Palace Hotel in New York City. Illumina is scheduled to speak at 11:00 am ET that morning. The presentation will be lead by Illumina Chief Financial Officer and Senior Vice President of Corporate Development Christian Henry. During the presentation, Mr. Henry will give a brief overview of the company, followed by a question and answer session. Interested parties who are unable to attend the event may hear Mr. Henry’s presentation via webcast at http://www.illumina.com/ on the Corporate/Investor Information page.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Illumina, Inc. is a developer, manufacturer and marketer of integrated systems for the large-scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that serve the sequencing, genotyping and gene expression markets. It also, develops and commercializes sequencing technologies used to perform a range of analyses, including whole genome re-sequencing, gene expression analysis and small ribonucleic acid (RNA) analysis. Its customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies. The Company operates in two business segments: Life Sciences and Diagnostics. On August 1, 2008, the Company acquired Avantome, Inc. The Company’s subsidiary is Solexa, Inc.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
